Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-013684
Filing Date
2017-11-02
Accepted
2017-11-02 19:31:27
Documents
1
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4104
  Complete submission text file 0001179110-17-013684.txt   5502
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 83216 GAITHERSBURG MD 20883-3216
Business Address
LAPOINTE ANTHONY GREGG (Reporting) CIK: 0001331860 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 171174258